SkinBioTherapeutics is a life sciences company focused on skin health. We are listed on the AIM market of the London Stock Exchange under the ticker SBTX.
Our portfolio of products and services spans topical products, oral supplements, intellectual property for outlicensing, and manufacturing. We address skin health through two complementary routes: from the outside in, and from the inside out. Together, these approaches create a scalable portfolio that supports skin function at every layer.
Our brands include Dermatonics, a clinically trusted topical range with over 15 years of heritage in foot and hand care; AxisBiotix, a consumer food supplement that targets skin health through the gut-skin axis; intellectual property around SkinBiotix, and Bio-Tech Solutions is our manufacturing division, which gives the group end-to-end production capability.
For all investor enquiries, contact us at ir@skinbiotix.com.